International Clinical Trial: A multicenter, Double-blind, Randomized Study to compare the effectiveness of JAQBO(R)(Zastaprazan citrate) and Proton Pump Inhibitor in Preventing Upper Gastrointestinal Events Due to Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Patients with High Bleeding Risk(Z-DAPT-HBR)

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (KCT0011722) titled 'A multicenter, Double-blind, Randomized Study to compare the effectiveness of JAQBO(R)(Zastaprazan citrate) and Proton Pump Inhibitor in Preventing Upper Gastrointestinal Events Due to Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Patients with High Bleeding Risk(Z-DAPT-HBR)' on March 13.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Seoul National University Bundang Hospital

Condition:

Diseases of the circulatory system

Inter...